Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.
If you're faculty at a teaching college with minimal NIH funding history and want to run a small clinical trial while mentoring undergrads, this covers it—but you must include a live trial component.
Report stale or inaccurate summary
What this is
This is an NIH AREA (Academic Research Enhancement Award) designed for colleges and universities that primarily grant bachelor's degrees and have received less than $6 million per year in NIH funding over the past 7 years. The funding supports faculty-led research that provides undergraduate students with hands-on biomedical research experience while strengthening the institution's research infrastructure. All projects must include a mechanistic or minimal-risk clinical trial component—studies that don't require FDA oversight, don't formally test drug efficacy, and carry low risk of harm.
Who can apply
Applicant institution must award baccalaureate science degrees and have received no more than $6 million per year in total NIH support (direct + indirect costs) in at least 4 of the last 7 fiscal years. Public, private, and state-controlled colleges and universities are eligible; for multi-school institutions, the $6M threshold applies to non-health-professional schools collectively.
Eligible applicant types
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Public and State controlled institutions of higher education
- Private institutions of higher education
Full description — from the agency
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F and A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole. This Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For the purpose of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.
Topics: nih research funding · undergraduate research · clinical trials · biomedical research · area grant · institution capacity building
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.